These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897 [TBL] [Abstract][Full Text] [Related]
5. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients. Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421 [TBL] [Abstract][Full Text] [Related]
7. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302 [TBL] [Abstract][Full Text] [Related]
8. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468 [TBL] [Abstract][Full Text] [Related]
9. MYC is a critical target of FBXW7. Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Palomero T; Ferrando A Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842 [TBL] [Abstract][Full Text] [Related]
11. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Jenkinson S; Koo K; Mansour MR; Goulden N; Vora A; Mitchell C; Wade R; Richards S; Hancock J; Moorman AV; Linch DC; Gale RE Leukemia; 2013 Jan; 27(1):41-7. PubMed ID: 22814294 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999 [TBL] [Abstract][Full Text] [Related]
13. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation. Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416 [TBL] [Abstract][Full Text] [Related]